Early life stress causes refractoriness to haloperidol-induced catalepsy

Molecular Pharmacology

Volumn 84, Issue 2, 2013, Pages 244-251

  Marrocco, Jordan ^a   Mairesse, Jérôme ^b   Bucci, Domenico ^c   Lionetto, Luana ^e   Battaglia, Giuseppe ^c   Consolazione, Michol ^b   Ravasi, Laura ^d   Simmaco, Maurizio ^e   Morley Fletcher, Sara ^b   Maccari, Stefania ^b   Nicoletti, Ferdinando ^c,f  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^c IRCCS NEUROMED   (Italy)

^d UNIV LILLE   (France)

^e St Andrea Hospital   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; HALOPERIDOL; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BEHAVIOR; BRAIN CORTEX; CATALEPSY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; EARLY LIFE STRESS; FEMALE; IMMOBILIZATION STRESS; NERVE CELL PLASTICITY; NONHUMAN; ONCOGENE C FOS; PREGNANCY; PRIORITY JOURNAL; PROGENY; PSYCHOLOGICAL REFRACTORY PERIOD; RAT; STEREOMETRY;

ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; CATALEPSY; CATECHOLAMINES; CEREBRAL CORTEX; DOPAMINE AGONISTS; FEMALE; GLOBUS PALLIDUS; HALOPERIDOL; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL RELATIONS; PREGNANCY; PROTO-ONCOGENE PROTEINS C-FOS; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE; STRESS, PHYSIOLOGICAL; SUBTHALAMIC NUCLEUS; VENTRAL THALAMIC NUCLEI;

EID: 84880574967     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.085530     Document Type: Article

References (60)

1. Adrover E, Berger MA, Pérez AA, Tarazi FI, and Antonelli MC (2007) Effects of prenatal stress on dopamine D2 receptor asymmetry in rat brain. Synapse 61: 459-462.
2. Antelman SM, Caggiula AR, Kocan D, Knopf S, Meyer D, Edwards DJ, and Barry H, 3rd (1991) One experience with 'lower' or 'higher' intensity stressors, respectively enhances or diminishes responsiveness to haloperidol weeks later: implications for understanding drug variability. Brain Res 566:276-283.
3. Antelman SM, Kocan D, Knopf S, Edwards DJ, and Caggiula AR (1992) One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci 51:261-266.
4. Ayd FJ, Jr (1961) Neuroleptics and extrapyramidal reactions in psychiatric patients. Rev Can Biol 20:451-459.
5. Barnes DE, Robinson B, Csernansky JG, and Bellows EP (1990) Sensitization versus tolerance to haloperidol-induced catalepsy: multiple determinants. Pharmacol Biochem Behav 36:883-887.
6. Bennouar KE, Uberti MA, Melon C, Bacolod MD, Jimenez HN, Cajina M, Kerkerian-Le Goff L, Doller D, and Gubellini P (2013) Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia. Neuropharmacology 66:158-169.
7. Bouwalerh H, Marrocco J, Mairesse J, Cassano T, Cannella M, Motolese M, Bucci D, Battaglia G, Pittaluga A, Calabresi P, Ravasi L, Morley-Fletcher S, Nicoletti F, Maccari S (2012) Prenatal stress induces a pre-parkinsonian phenotype in rats (Abstract 388.13). Society for Neuroscience Annual Meeting; 2012 October 13-17; New Orleans, LA.
8. Brody EB (1981) Can mother-infant interaction produce vulnerability to schizophrenia? J Nerv Ment Dis 169:72-81.
9. Casey DE (1990) Tardive dyskinesia. West J Med 153:535-541.
10. Casey DE and Keepers GA (1988) Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. Psychopharmacol Ser 5:74-93.
11. Castagné V, Moser PC, and Porsolt RD (2009) Preclinical behavioral models for predicting antipsychotic activity. Adv Pharmacol 57:381-418.
12. Chopde CT, Hote MS, Mandhane SN, and Muthal AV (1995) Glucocorticoids attenuate haloperidol-induced catalepsy through adrenal catecholamines. J Neural Transm 102:47-54.
13. Conn PJ, Battaglia G, Marino MJ, and Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787-798.
14. Darnaudéry M and Maccari S (2008) Epigenetic programming of the stress response in male and female rats by prenatal restraint stress. Brain Res Brain Res Rev 57:571-585.
15. Deminière JM, Piazza PV, Guegan G, Abrous N, Maccari S, Le Moal M, and Simon H (1992) Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res 586:135-139.
16. Di Chiara G and Gessa GL (1978) Pharmacology and neurochemistry of apomorphine. Adv Pharmacol Chemother 15:87-160.
17. Dragunow M and Faull R (1989) The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29:261-265.
18. Fanselow MS and Dong HW (2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65:7-19.
19. González-Lugo OE, Ceballos-Huerta F, Jiménez-Capdeville ME, Arankowsky-Sandoval G, and Góngora-Alfaro JL (2010) Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: a potential treatment for extrapyramidal syndromes. Prog Neuropsychopharmacol Biol Psychiatry 34:1465-1471.
20. Goudet C, Vilar B, Courtiol T, Deltheil T, Bessiron T, Brabet I, Oueslati N, Rigault D, Bertrand HO, and McLean H et al. (2012) A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential. FASEB J 26:1682-1693.
21. Haase HJ (1954) [Occurrence and interpretation of psychomotor parkinsonism in megaphen or largactil prolonged therapy]. Nervenarzt 25:486-492.
22. Hausknecht K, Haj-Dahmane S, and Shen R-Y (2013) Prenatal stress exposure increases the excitation of dopamine neurons in the ventral tegmental area and alters their reponses to psychostimulants. Neuropsychopharmacology 38:293-301.
23. Henry C, Guegant G, Cador M, Arnauld E, Arsaut J, Le Moal M, and Demotes-Mainard J (1995) Prenatal stress in rats facilitates amphetamine-induced sensitization and induces long-lasting changes in dopamine receptors in the nucleus accumbens. Brain Res 685:179-186.
24. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, and Murray RM (2004) Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol 7 (Suppl 1):S7-S13.
25. Jones CK, Bubser M, Thompson AD, Dickerson JW, Turle-Lorenzo N, Amalric M, Blobaum AL, Bridges TM, Morrison RD, and Jadhav S et al. (2012) The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease. J Pharmacol Exp Ther 340:404-421.
26. Keepers GA, Clappison VJ, and Casey DE (1983) Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes. Arch Gen Psychiatry 40: 1113-1117.
27. King MA, Scotty N, Klein RL, and Meyer EM (2002) Particle detection, number estimation, and feature measurement in gene transfer studies: optical fractionator stereology integrated with digital image processing and analysis. Methods 28: 293-299.
28. Kippin TE, Szumlinski KK, Kapasova Z, Rezner B, and See RE (2008) Prenatal stress enhances responsiveness to cocaine. Neuropsychopharmacology 33:769-782.
29. Koenig JI, Kirkpatrick B, and Lee P (2002) Glucocorticoid hormones and early brain development in schizophrenia. Neuropsychopharmacology 27:309-318.
30. Koenig JI, Elmer GI, Shepard PD, Lee PR, Mayo C, Joy B, Hercher E, and Brady DL (2005) Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 156:251-261.
31. Kovács KJ (1998) c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int 33:287-297.
32. Lett TAP, Wallace TJM, Chowdhury NI, Tiwari AK, Kennedy JL, and Müller DJ (2012) Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry 17:242-266.
33. Leucht S, Kissling W, and Davis JM (2009) Second-generation antipsychotics for schizophrenia: can we resolve the conflict? Psychol Med 39:1591-1602.
34. Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, and Keith S (1998) The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective. J Clin Psychopharmacol 18(2, Suppl 1):20S-24S.
35. Lipska BK and Weinberger DR (1993) Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Brain Res Dev Brain Res 75:213-222.
36. Lipska BK, Jaskiw GE, Braun AR, and Weinberger DR (1995) Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphineinduced stereotypic behaviors in the rat. Biol Psychiatry 38:255-262.
37. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, and Szymanski SR (1992) Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149:1183-1188.
38. Maccari S, Piazza PV, Kabbaj M, Barbazanges A, Simon H, and Le Moal M (1995) Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress. J Neurosci 15:110-116.
39. Mairesse J, Vercoutter-Edouart AS, Marrocco J, Zuena AR, Giovine A, Nicoletti F, Michalski JC, Maccari S, and Morley-Fletcher S (2012) Proteomic characterization in the hippocampus of prenatally stressed rats. J Proteomics 75:1764-1770.
40. Melzacka M, Wiszniowska G, and Vetulani J (1978) The distribution of apomorphine in rat brain: possible behavioral correlates. Pol J Pharmacol Pharm 30:335-345.
41. Mandhane SN, Chopde CT, and Ghosh AK (1997) Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats. Eur J Pharmacol 328:135-141.
42. Marrocco J, Mairesse J, Ngomba RT, Silletti V, Van Camp G, Bouwalerh H, Summa M, Pittaluga A, Nicoletti F, and Maccari S et al. (2012) Anxiety-like behavior of prenatally stressed rats is associated with a selective reduction of glutamate release in the ventral hippocampus. J Neurosci 32:17143-17154.
43. Matrisciano F, Tueting P, Dalal I, Kadriu B, Grayson DR, Davis JM, Nicoletti F, and Guidotti A (2012a) Epigenetic modifications of GAB Aergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice. Neuropharmacology doi: 10.1016/j.neuropharm.2012.04.013 [published ahead of print].
44. Matrisciano F, Tueting P, Maccari S, Nicoletti F, and Guidotti A (2012b) Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. Neuropsychopharmacology 37:929-938.
45. Moo-Puc RE, Góngora-Alfaro JL, Alvarez-Cervera FJ, Pineda JC, Arankowsky-Sandoval G, and Heredia-López F (2003) Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. Neuropharmacology 45:493-503.
46. Morley-Fletcher S, Darnaudery M, Koehl M, Casolini P, Van Reeth O, and Maccari S (2003) Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine. Brain Res 989:246-251.
47. Morley-Fletcher S, Puopolo M, Gentili S, Gerra G, Macchia T, and Laviola G (2004) Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug-induced motor alterations in adolescent female rats. Eur J Pharmacol 489:89-92.
48. Morley-Fletcher S, Mairesse J, Soumier A, Banasr M, Fagioli F, Gabriel C, Mocaer E, Daszuta A, McEwen B, and Nicoletti F et al. (2011) Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats. Psychopharmacology (Berl) 217:301-313.
49. Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19 (Suppl 1):1-93.
50. Niswender CM, Johnson KA, Weaver CD, Jones CK, Xiang Z, Luo Q, Rodriguez AL, Marlo JE, de Paulis T, and Thompson AD et al. (2008) Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol Pharmacol 74:1345-1358.
51. Ossowska K (2002) Neuronal basis of neuroleptic-induced extrapyramidal side effects. Pol J Pharmacol 54:299-312.
52. Read J, Perry BD, Moskowitz A, and Connolly J (2001) The contribution of early traumatic events to schizophrenia in some patients: a traumagenic neurodevelopmental model. Psychiatry 64:319-345.
53. Reagan-Shaw S, Nihal M, and Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661.
54. Robinson DG, Woerner MG, Delman HM, and Kane JM (2005) Pharmacological treatments for first-episode schizophrenia. Schizophr Bull 31:705-722.
55. Sawyer SF, Martone ME, and Groves PM (1991) A GABA immunocytochemical study of rat motor thalamus: light and electron microscopic observations. Neuroscience 42:103-124.
56. Sullivan R, Wilson DA, Feldon J, Yee BK, Meyer U, Richter-Levin G, Avi A, Michael T, Gruss M, and Bock J et al. (2006) The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development. Dev Psychobiol 48:583-602.
57. Thomas MB, Hu M, Lee TM, Bhatnagar S, and Becker JB (2009) Sex-specific susceptibility to cocaine in rats with a history of prenatal stress. Physiol Behav 97: 270-277.
58. Ushijima I, Kawano M, Kaneyuki H, Suetsugi M, Usami K, Hirano H, Mizuki Y, and Yamada M (1997) Dopaminergic and cholinergic interaction in cataleptic responses in mice. Pharmacol Biochem Behav 58:103-108.
59. Van Putten T, Marder SR, Wirshing WC, Aravagiri M, and Chabert N (1991) Neuroleptic plasma levels. Schizophr Bull 17:197-216.
60. Xiang Z, Thompson AD, Jones CK, Lindsley CW, and Conn PJ (2012) Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease. J Pharmacol Exp Ther 340:595-603.